Latest news with #Rubix
New Indian Express
7 days ago
- Business
- New Indian Express
India's pharma exports rise 9.3% to $30.5 billion in FY25; complex generics and global expansion drive growth
CHENNAI: India's pharmaceutical exports reached US$30.5 billion in FY2025, marking a 9.3% increase from the previous year, according to a new report by Rubix Data Sciences, a leading provider of risk management and monitoring solutions. The report projects that the country's pharma exports could double to US$65 billion by 2030. Complex generics and global expansion drive the growth, highlighting how Indian pharmaceutical companies are navigating global uncertainty by focusing on complex generics, expanding international operations, and strengthening regulatory capabilities. 'India's strength comes at a time of rising external volatility,' the report states. The United States, which accounts for over 32% of India's pharma exports, is reportedly mulling a 200% tariff on pharmaceutical imports—raising serious implications for India's export-driven pharma sector. 'But India is not standing still. From strategic acquisitions by Indian CDMOs (Contract Development and Manufacturing Organisations) in the US and Europe to the increasing share of complex generics in their product mix, Indian companies are proactively mitigating these risks,' the report adds. According to Rubix, Indian pharma companies are responding by investing in US-focused manufacturing capabilities, enhancing regulatory compliance, and developing complex generics targeted at upcoming patent expiries. With a series of high-value global drug patents set to expire over the next five years, Indian players are positioning themselves to fill the resulting supply gaps. 'The surge in pharma exports this year is encouraging, but it also reflects how Indian manufacturers are recalibrating in response to global uncertainties. From navigating tariff pressures to strengthening compliance and expanding globally, the sector is showing clear signs of strategic maturity. We believe this momentum will continue as companies focus more on complex generics and strengthen their specialised capabilities,' said Mohan Ramaswamy, Co-founder and CEO of Rubix Data Sciences. The report identifies a clear shift in strategic priorities among Indian pharma firms. Companies are increasingly entering advanced therapeutic segments such as oncology, anti-diabetics, and central nervous system (CNS) disorders. Many are also scaling up their global presence through acquisitions and partnerships, particularly in developed markets, to bolster supply chain continuity and meet evolving regulatory demands. With 74% of India's bulk drug imports still sourced from China, the report underscores the growing urgency to diversify both supply chains and customer bases as a key lever for long-term resilience. As the August 1 tariff deadline looms, decisions by Indian policymakers and businesses could significantly influence not just India's pharma trajectory, but the health of millions worldwide who rely on its medicines, the report concludes.
Canada News.Net
15-07-2025
- Business
- Canada News.Net
India on course to become world's 4th largest economy, surpassing Japan amid looming US tariffs: Rubix Report
New Delhi [India], July 14 (ANI): India is on track to become the world's fourth-largest economy in 2025, surpassing Japan, marking a significant shift in Asia's economic balance, according to the latest Rubix Country Insights Report: Japan by Rubix Data Sciences. According to the report, the United States is preparing to impose 25 per cent tariffs on Japanese exports starting August 1, Japan faces mounting economic pressures that threaten to further dampen growth, said a recent report by Rubix. Additionally, the reports reveal that Japan's economy, once a pillar of regional strength, grew just 0.1 per cent in 2024. Weak household spending, surging import costs, and persistent inflation at 3.7 per cent have weighed on the recovery. The Bank of Japan has cautiously raised interest rates, but looming US tariffs, expected to reduce GDP growth by 0.26 percentage points and slash exporter profits by up to 25 per cent, pose a serious threat, particularly to Japan's vital automotive sector. Despite these headwinds, Japan's corporate sector is showing resilience. M&A activity reached a four-decade high in 2024, with deals exceeding USD 230 billion--a 44% jump. Major transactions like Nippon Steel's acquisition of U.S. Steel and Bain Capital's healthcare investments underscore Japanese firms' drive for global expansion. In parallel, India's GDP is projected to edge past Japan's in 2025, reaching USD 4,187 billion. Furthermore, the Rubix report believes this is a deepening partnership. Bilateral trade has grown at a 13% CAGR to exceed USD 25 billion in FY2025, though India's trade deficit with Japan has nearly doubled. Automobiles now account for 13% of India's exports to Japan, up from just 1 per cent four years ago, signalling India's emergence as a key supplier. Japanese imports from India have grown steadily, while investments in India's manufacturing, clean energy, and infrastructure sectors are rising rapidly. Beyond trade, the two nations are collaborating on semiconductors, defence, and digital infrastructure. 'The world's fourth- and fifth-largest economies deepening their trade and strategic ties augurs well for Asia's economic future. Our report shows how this partnership is unlocking concrete business opportunities, from rising Indian exports of automobiles and smartphones to Japan to record Japanese investments in India's manufacturing, energy, and infrastructure sectors,' said Mohan Ramaswamy, CEO of Rubix Data Sciences. (ANI)
India Gazette
14-07-2025
- Business
- India Gazette
India on course to become world's 4th largest economy, surpassing Japan amid looming US tariffs: Rubix Report
New Delhi [India], July 14 (ANI): India is on track to become the world's fourth-largest economy in 2025, surpassing Japan, marking a significant shift in Asia's economic balance, according to the latest Rubix Country Insights Report: Japan by Rubix Data Sciences. According to the report, the United States is preparing to impose 25 per cent tariffs on Japanese exports starting August 1, Japan faces mounting economic pressures that threaten to further dampen growth, said a recent report by Rubix. Additionally, the reports reveal that Japan's economy, once a pillar of regional strength, grew just 0.1 per cent in 2024. Weak household spending, surging import costs, and persistent inflation at 3.7 per cent have weighed on the recovery. The Bank of Japan has cautiously raised interest rates, but looming US tariffs, expected to reduce GDP growth by 0.26 percentage points and slash exporter profits by up to 25 per cent, pose a serious threat, particularly to Japan's vital automotive sector. Despite these headwinds, Japan's corporate sector is showing resilience. M&A activity reached a four-decade high in 2024, with deals exceeding USD 230 billion--a 44% jump. Major transactions like Nippon Steel's acquisition of U.S. Steel and Bain Capital's healthcare investments underscore Japanese firms' drive for global expansion. In parallel, India's GDP is projected to edge past Japan's in 2025, reaching USD 4,187 billion. Furthermore, the Rubix report believes this is a deepening partnership. Bilateral trade has grown at a 13% CAGR to exceed USD 25 billion in FY2025, though India's trade deficit with Japan has nearly doubled. Automobiles now account for 13% of India's exports to Japan, up from just 1 per cent four years ago, signalling India's emergence as a key supplier. Japanese imports from India have grown steadily, while investments in India's manufacturing, clean energy, and infrastructure sectors are rising rapidly. Beyond trade, the two nations are collaborating on semiconductors, defence, and digital infrastructure. 'The world's fourth- and fifth-largest economies deepening their trade and strategic ties augurs well for Asia's economic future. Our report shows how this partnership is unlocking concrete business opportunities, from rising Indian exports of automobiles and smartphones to Japan to record Japanese investments in India's manufacturing, energy, and infrastructure sectors,' said Mohan Ramaswamy, CEO of Rubix Data Sciences. (ANI)
&w=3840&q=100)
First Post
08-07-2025
- Business
- First Post
How much is Brics worth for India? A look at business, trade links
India's total trade with Brics nations touched $399 billion in 2024, growing at an annual rate of 20 per cent since 2020. The platform gives India access to vast markets, although trade deficits need to be addressed read more India's trade ties with the Brics bloc are expanding rapidly, as the country deepens its economic engagement with a group that now represents nearly half the world's population and about 40 per cent of global GDP. However, the surge in trade volumes has come with widening deficits, particularly with China and Russia, raising questions about the sustainability and strategic value of these partnerships, according to a report by Rubix Data Sciences. The Brics grouping, originally comprising Brazil, Russia, India, China, and South Africa, now includes Egypt, Ethiopia, Indonesia, Iran, Saudi Arabia, and the United Arab Emirates. Together, the 11-member bloc accounted for $10.5 trillion in trade in 2024, with Brics nations emerging as net exporters in global merchandise flows. STORY CONTINUES BELOW THIS AD India's growing trade with Brics India's total trade with Brics nations touched $399 billion in 2024, growing at an annual rate of 20 per cent since 2020. However, the country's trade deficit with Brics widened nearly threefold over the same period, from $68 billion to $209 billion. Imports from Brics countries reached $304 billion last year, up 24 per cent annually since 2020. That now accounts for 43 per cent of India's total imports, a significant rise from 35 per cent just four years earlier. A major driver of this surge is Russia, which has become India's top crude oil supplier. India imported an average of 1.76 million barrels per day from Russia in FY2025, making up 35 per cent of its total oil imports. Imports from the UAE, Indonesia, and China have also risen sharply. A lopsided equation? India exported $95 billion worth of goods to Brics countries in 2024, reflecting a slower growth rate of 11 per cent per year since 2020. These exports make up about 22 per cent of India's total export basket. While exports to South Africa, the UAE, Saudi Arabia, and Brazil have grown at healthy rates, the overall trade balance remains skewed. China alone accounted for a $94 billion trade deficit in 2024. Bilateral trade with China grew to $124 billion, but Indian exports to the country have fallen 6 per cent since 2020, while imports from China rose 17 per cent, driven largely by high-value electronics and industrial inputs, according to the Rubix report. Russia is another key concern. India's trade deficit with Moscow ballooned to $59 billion, up eighteenfold since 2020, mainly due to rising oil imports following the Ukraine war. Some bright spots Among the more balanced relationships is Brazil, with which India has no trade deficit. India's exports to Brazil, dominated by agrochemicals and petroleum products, have grown 16 per cent annually. Imports, largely sugar and agricultural products, grew at 13 per cent annually. India is also a major refiner and exporter of petroleum products within the bloc. With over 250 million metric tonnes of refining capacity, India ranks seventh globally in refined product exports, which feature prominently in its trade with at least six Brics partners. STORY CONTINUES BELOW THIS AD
Time of India
22-06-2025
- Business
- Time of India
Agrochem market may hit $14.5 bn by FY28; herbicide exports jump; sector set for 9% CAGR: Report
India's agrochemicals industry is forecast to grow to $14.5 billion by 2027-28, clocking a compound annual growth rate (CAGR) of 9 per cent, even as global headwinds persist, Rubix Data Sciences said in its latest outlook. The research firm pegs the current market size at $11.2 billion for 2024-25, up 8.7 per cent year-on-year despite a tough external environment marked by inventory destocking, aggressive Chinese price competition and muted demand in key export destinations. Agrochemical exports fell 22 per cent in FY 24 for the reasons above. Rubix, however, expects a 'moderate recovery' in 2024-25 as global supply chains stabilise and Indian players leverage their cost competitiveness. Herbicides outpace other segments A standout trend is the surge in herbicide shipments, which logged a 20 per cent CAGR between FY 20 and FY 25, lifting their share of total agrochemical exports from 31 per cent to 37 per cent. Rising farm-labour costs worldwide and India's ability to deliver affordable crop-protection solutions are driving demand. Japan has edged past Brazil as the second-largest buyer of Indian herbicides, while the United States and Brazil remain the top markets for insecticides and fungicides. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo 'Sector resilient, adapting fast' 'The drop in agrochemical exports over the past year has definitely been a setback, but it's also part of a larger global reset,' said Mohan Ramaswamy, co-founder and CEO, Rubix Data Sciences. 'What we are seeing now is Indian manufacturers adapting fast, whether it's by improving cost efficiency, diversifying portfolios, or tapping into new markets. The sector is resilient, and we believe the recovery under way will be steady and sustainable. At Rubix, we are committed to helping businesses make sense of these shifts through data-led insights that support smarter decisions and long-term growth,' he added. Rubix believes the combination of cost-competitive manufacturing, product diversification and new-market penetration will help the industry navigate global challenges and sustain momentum towards the $14.5-billion mark.
